Comparison

ARRY-403 European Partner

Item no. TMO-T30142-5mg
Manufacturer TargetMol
CASRN 1138669-65-4
Amount 5 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles Cc1ncccc1Oc1cc(Sc2ccccn2)cnc1Nc1nc(ns1)[C@H](O)CO
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AMG-151,ARRY 403,ARRY403,ARRY-403,AMG151,AMG 151
Shipping Condition Cool pack
Available
Manufacturer - Targets
Glucokinase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
454.52
Description
ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
Pathways
Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close